Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis

Clinical and Experimental Immunology

Volumn 106, Issue 3, 1996, Pages 529-533

  Hommes, D W ^a,b   Meenan, J ^a   Dijkhuizen, S ^a   Ten Kate, F J W ^a   Tytgat, G N J ^a   Van Deventer, S J H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Colitis; Eicosanoids; G CSF; Neutrophil

Indexed keywords

LEUKOTRIENE B4; MYELOPEROXIDASE; PROSTAGLANDIN E2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFICACY; ENTERITIS; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029806837     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-863.x     Document Type: Article

References (23)

1. Schaub J, Heyne K. Glycogen storage disease type Ib. Eur J Pediatr 1983; 140:283-8.
2. Wendel U, Bremer HJ, Willberg B. Inflammatory bowel disease in glycogen storage disease Ib. J Pediatr 197; 110:166.
3. Sanderson IR, Bisset WM, Milla PJ, Leonard JV. Chronic inflammatory bowel disease in glycogen storage disease type Ib. J Inher Metab Dis 1991; 14:771-6.
4. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony stimulating factors. N Eng J Med 1992; 326:1666-9.
5. Ambruso DR, Thurman GW, Cusack NA, Occena R, Sokol RJ. G-CSF treatment of a patient with glycogen storage disease (GSD) Ib resolved ulcerative colitis but had no effect on functional capacity of neutrophils. Blood 1993; 82:2015 (Abstr.).
6. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78:2791-808.
7. Steward WP. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 1993; 342:153-7.
8. Hartung T, Volk H, Wendel A. G-CSF - an anti-inflammatory cytokine. J Endotox Res 1995; 2:1-7.
9. Dale DC. Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. Clin Infect Dis 1994; 18(S2):S180-S188.
10. Meenan J, Grool TA, Hommes DW et al. Lexipafant (BB-882), a platelet activating factor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol 1996; 8:569-73.
11. 2-integrin inhibitor. Scand J Gastroenterol 1996; in press.
12. Grool TA, Meenan J, van Dullemen HM, ten Kate FJW, Le Beaut A, Tytgat GNJ, van Deventer SJH. Anti-inflammatory effect of IL10 in a rabbit model of immune-complex induced colitis. Gastroenterology 1996; 110 (Abstr.): 918.
13. Nathan CF. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 1989; 73:301.
14. Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F. Recombinant granulocyte colony-stimulating factor enhances Superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun 1987; 144:1143.
15. Ohsaka A, Kitagawa S, Sakamoto S, Miura S, Takanashi N, Takaku F, Saito F. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989; 74:2743.
16. Lubbert M, Brugger W, Mertelsmann R, Kanz L. Developmental regulation of myeloid gene expression and demethylation during exvivo culture of peripheral blood progenitor cells. Blood 1996; 87:447-55.
17. Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, Tytgat GNJ, van Deventer SJH. Inflammatory bowel disease is associated with raised levels of bactericidal/permeability increasing protein. Gastroenterology 1996; 110:733-9.
18. Hommes DW, Meenan J, de Haas M, ten Kate FJW, von dem Borne AEGKr, Tytgat GNJ, van Deventer SJH. Soluble Fc gamma receptor III (CD16) and eicosanoids in gut lavage fluid from patients with inflammatory bowel disease: relation with mucosal inflammation. Gut 1996; 38:564-7.
19. Wallace JL. Eicosanoids. In: Targen SR, Shanahan F, ed. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins 1994:123-32.
20. O'Reilly M, Silver GM, Greenhaigh DG, Gamelli RL, Davis JH, Hebert JC. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 1992; 33:679.
21. Gorgen I, Hartung T, Leist M, Niehorster M, Tiegs G, Uhlig S, Weitzel F, Wendel A. Granulocyte colony-stimulating factor treatment protects rodent against LPS-induced toxicity via suppression of systemic tumor necrosis factor α. J Immunol 1992; 149:918.
22. van Dullemen HM, van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, Woody J. Treatment of severe Crohn's disease with anti-tumour necrosis factor chemieric monoclonal antibody (cA2). Gastroenterology 1995; 109:129-35.
23. Trevani AS, Fontan PA, Andonegui GA, Isturitz MA, Geffner JR. Neutrophil chemotaxis induced by immune complexes. Clin Immun Immunopathol 1994; 74:104-11.